During this presentation we welcome, Shuttle Pharma. Shuttle Pharma (Nasdaq: SHPH) is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). The Company’s mission is to improve the lives of cancer patients by developing therapies that are designed to maximize the effectiveness of RT while limiting the side effects of radiation in cancer treatment.

This Company Webcast was recorded during the Lytham Partners Fall 2024 Investor Conference.